Literature DB >> 23236098

The Headache Under-Response to Treatment (HURT) Questionnaire: assessment of utility in headache specialist care.

Maria L S Westergaard1, Timothy J Steiner, E Anne MacGregor, Fabio Antonaci, Cristina Tassorelli, Dawn C Buse, Richard B Lipton, Rigmor H Jensen.   

Abstract

The HURT Questionnaire consists of eight questions which the patient answers as a measure of effectiveness of intervention against headache. This first assessment of clinical utility was conducted in headache specialist centres in three countries in order to demonstrate that HURT was responsive to change induced by effective management. We administered HURT on three occasions to 159 consecutive patients seeking non-urgent care from centres in Denmark and the United Kingdom: the first before the initial visit to the centres; the second at the initial visit; and the third when the specialist judged that the best possible outcome had been achieved in each patient. Questionnaires were also answered by 42 patients at initial and final visits to a centre in Italy. Internal consistency reliability was very good (α = 0.85) while test-retest reliability was fair to low (κ = 0.38-0.62 and r (s) = 0.49-0.76), possibly because headache was unstable prior to start of management. There were significant changes in responses post-intervention compared with baseline (p < 0.01), indicating a favourable outcome overall in up to 77% of patients, and responsiveness to change, but there was no improvement in patients' concerns about side effects of medication (p = 0.18). We conclude that the questionnaire has utility across headache disorders. It can help patients describe headache frequency and headache-attributed disability, medication use/efficacy/tolerability, self-efficacy and knowledge about headache. It may guide physicians in assessment of disability of individual patients, how to proceed with management towards the best possible outcome, and in evaluating the quality of management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23236098     DOI: 10.1177/0333102412469740

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  10 in total

1.  Headache Gauge: a real-life calendar-based tool for headache monitoring.

Authors:  Raquel Gil-Gouveia; Inês Brás Marques; Elsa Paixão Parreira; Isabel Pavão Martins; António Gouveia Oliveira
Journal:  Neurol Sci       Date:  2021-02-04       Impact factor: 3.307

2.  Evaluation of headache service quality indicators: pilot implementation in two specialist-care centres.

Authors:  Zaza Katsarava; Raquel Gil Gouveia; Rigmor Jensen; Charly Gaul; Sara Schramm; Anja Schoppe; Timothy J Steiner
Journal:  J Headache Pain       Date:  2015-06-09       Impact factor: 7.277

3.  Headache service quality: evaluation of quality indicators in 14 specialist-care centres.

Authors:  Sara Schramm; Derya Uluduz; Raquel Gil Gouveia; Rigmor Jensen; Aksel Siva; Ugur Uygunoglu; Giorgadze Gvantsa; Maka Mania; Mark Braschinsky; Elena Filatova; Nina Latysheva; Vera Osipova; Kirill Skorobogatykh; Julia Azimova; Andreas Straube; Ozan Emre Eren; Paolo Martelletti; Valerio De Angelis; Andrea Negro; Mattias Linde; Knut Hagen; Aleksandra Radojicic; Jasna Zidverc-Trajkovic; Ana Podgorac; Koen Paemeleire; Annelien De Pue; Christian Lampl; Timothy J Steiner; Zaza Katsarava
Journal:  J Headache Pain       Date:  2016-12-08       Impact factor: 7.277

4.  Quality indicators in headache care: an implementation study in six Italian specialist-care centres.

Authors:  L Pellesi; S Benemei; V Favoni; C Lupi; E Mampreso; A Negro; M Paolucci; T J Steiner; M Ulivi; S Cevoli; S Guerzoni
Journal:  J Headache Pain       Date:  2017-05-05       Impact factor: 7.277

Review 5.  The Global Campaign turns 18: a brief review of its activities and achievements.

Authors:  Timothy J Steiner; Gretchen L Birbeck; Rigmor H Jensen; Paolo Martelletti; Lars Jacob Stovner; Derya Uluduz; Matilde Leonardi; Jes Olesen; Zaza Katsarava
Journal:  J Headache Pain       Date:  2022-04-21       Impact factor: 8.588

6.  HURT (Headache Under-Response to Treatment) questionnaire in the management of primary headache disorders: reliability, validity and clinical utility of the Arabic version.

Authors:  Mohammed Al Jumah; Ali Al Khathaami; Hani Tamim; Abdulla Al Owayed; Suleiman Kojan; Ayah Jawhary; Richard Lipton; Dawn Buse; Richard Jensen; Timothy Steiner
Journal:  J Headache Pain       Date:  2013-02-21       Impact factor: 7.277

Review 7.  Recent advances in migraine therapy.

Authors:  Fabio Antonaci; Natascia Ghiotto; Shizheng Wu; Ennio Pucci; Alfredo Costa
Journal:  Springerplus       Date:  2016-05-17

8.  The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility.

Authors:  T J Steiner; D C Buse; M Al Jumah; M L Westergaard; R H Jensen; M L Reed; L Prilipko; F S Mennini; M J A Láinez; K Ravishankar; F Sakai; S-Y Yu; M Fontebasso; A Al Khathami; E A MacGregor; F Antonaci; C Tassorelli; R B Lipton
Journal:  J Headache Pain       Date:  2018-02-14       Impact factor: 7.277

9.  Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.

Authors:  Cristina Tassorelli; Licia Grazzi; Marina de Tommaso; Giulia Pierangeli; Paolo Martelletti; Innocenzo Rainero; Stefanie Dorlas; Pierangelo Geppetti; Anna Ambrosini; Paola Sarchielli; Eric Liebler; Piero Barbanti
Journal:  Neurology       Date:  2018-06-15       Impact factor: 9.910

Review 10.  Diagnosis and management of migraine in ten steps.

Authors:  Anna K Eigenbrodt; Håkan Ashina; Sabrina Khan; Hans-Christoph Diener; Dimos D Mitsikostas; Alexandra J Sinclair; Patricia Pozo-Rosich; Paolo Martelletti; Anne Ducros; Michel Lantéri-Minet; Mark Braschinsky; Margarita Sanchez Del Rio; Oved Daniel; Aynur Özge; Ayten Mammadbayli; Mihails Arons; Kirill Skorobogatykh; Vladimir Romanenko; Gisela M Terwindt; Koen Paemeleire; Simona Sacco; Uwe Reuter; Christian Lampl; Henrik W Schytz; Zaza Katsarava; Timothy J Steiner; Messoud Ashina
Journal:  Nat Rev Neurol       Date:  2021-06-18       Impact factor: 42.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.